Menu

Bionic Health: AI-Powered Health Guidance

Augmenting doctors with AI to help users live healthier lives

Written by

Alumni Ventures

Published on

Read

2 min

Alumni Ventures portfolio company Bionic Health is developing a consumer health platform powered by GPT-4. With the help of Microsoft, Bionic plans to scale its services by augmenting doctors with AI to deliver optimal health guidance.

Empowering Doctors with AI Insights

While artificial intelligence (AI) is far from the first groundbreaking healthtech innovation, it’s positioned to be one of the most impactful. AI could help the healthcare industry save up to $360 billion annually by improving clinical quality and safety, detecting adverse events, and streamlining continuity of care and referral management. Some reports even suggest that patients prefer when ChatGPT answers their healthcare questions.

Bionic Health is building a platform that combines longevity medicine and AI through the capabilities of GPT-4, the latest edition of OpenAI’s popular chatbot. Users would have access to unique, AI-driven modules focused on identifying the best solutions for improving their performance and recovery, diet and nutrition, and mental well-being.

Managing Partner Greg Baker on Bionic Health

See video policy below.

Bionic is working in partnership with doctors to complement in-person visits. This approach is intended to deliver a more scalable and customizable platform than a purely digital solution. Patients and physicians would pay a membership fee to access Bionic’s platform and reinforce the changes needed to optimize a patient’s health between visits.

Full membership features are expected to include:

  • Unlimited follow-ups via video, voice, and text messaging
  • Individualized treatment, medication, and/or supplement plans
  • Access to diagnostic testing for hormones, genetics, and more

What We Liked About the Company

  • Home

    Expert Founding Team

    CEO Robbie Allen previously founded several tech and AI startups like Automated Insights, a generative AI company acquired by Vista Equity Partners for $80 million.* CMO Jared Pelo is a former ER physician and previously founded iScribes, an ambient documentation technology startup acquired by Nuance Communications.**
  • Home

    Partnership with Microsoft

    Bionic has access to GPT-4 through a close relationship with Microsoft, which recently accepted the company into an incubation program.
  • Home

    Massive Market Opportunity

    The consumer health market is projected to more than double in value over the next decade, reaching $781.5 billion by 2030.***

How We’re Involved

Towerview Ventures (for the Duke community) sponsored AV’s investment in Bionic’s $3 million seed round, alongside AI Operator’s Fund, IDEA Fund Partners, Operator.VC, Studio VC, and Tweener Fund. AV’s AI Fund, Healthtech Fund, and Total Access Fund also participated in the round.

View Fund Performance
Login to our secure data room.

Schedule a Call to Speak with Us
Ask questions important to you.

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.

*Alyson Shontell, “A Startup That Uses Robots To Write News Gets Acquired for $80 Million in Cash,” Business Insider, February 23, 2015

**Business Observer Staff, “Scribed Success,” Observer Media Group, February 2, 2018

***Verified Market Research, “Global Consumer Healthcare Market Size And Forecast,” April 2023

Written by

Alumni Ventures

Alumni Ventures is a network-powered VC firm that helps accredited individuals invest in venture capital.

LinkedIn
Twitter
Facebook
Tagged with

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made. To see Important Disclosure Information, visit: https://av-funds.com/disclosures.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Investor Portal Update Policy: Investor portfolio data is updated once per quarter in the AV Investor Portal.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

(1) Internal Rate of Return (IRR) for AV Funds is net of management fees and incentive allocations applied to amounts distributed to investors, and gross of incentive allocations applicable to unrealized gains on investments held by AV Funds. IRR for AV Funds includes uninvested cash, unrealized investments, and amounts distributed to investors. The IRR shown for the Russell 2000 indices are gross of fees because indices are not managed investments, and it is not possible to invest directly in an index. For additional information see av-funds.com/disclosures. All investment involves risk, including risk of loss. Past performance is not necessarily indicative of future results. For more information on AV Funds’ investment returns, please see here.

Not an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are only made pursuant to the formal offering documents for the fund, that describe the risks (which are significant), terms, and other important information that must be considered before an investment decision is made.
To see additional risk factors and investment considerations, visit: https://av-funds.com/disclosures.

Please click here to view additional investor policies.

© 2024, Alumni Ventures. All rights reserved.